Identification using spectroscopy
    11.
    发明授权

    公开(公告)号:US10309894B2

    公开(公告)日:2019-06-04

    申请号:US15247554

    申请日:2016-08-25

    Abstract: A device may receive information identifying results of a spectroscopic measurement of an unknown sample. The device may perform a first classification of the unknown sample based on the results of the spectroscopic measurement and a global classification model. The device may generate a local classification model based on the first classification. The device may perform a second classification of the unknown sample based on the results of the spectroscopic measurement and the local classification model. The device may provide information identifying a class associated with the unknown sample based on performing the second classification.

    MEDICATION ASSURANCE SYSTEM AND METHOD
    12.
    发明申请

    公开(公告)号:US20190164640A1

    公开(公告)日:2019-05-30

    申请号:US16263972

    申请日:2019-01-31

    Abstract: A medication assurance system for verification of both the medication and the patient is disclosed. A portable spectrometer is used to obtain a light spectrum of the medication. A subject identification or biometric device is used to identify the patient. A controller coupled to the portable spectrometer and the subject identification device identifies the medication by performing a chemometric analysis of the light spectrum. Based on the medication identified and the patient identified, the controller can determine if the medication is to be taken by the patient.

    Medication assurance system and method

    公开(公告)号:US10216908B2

    公开(公告)日:2019-02-26

    申请号:US15600844

    申请日:2017-05-22

    Abstract: A medication assurance system for verification of both the medication and the patient is disclosed. A portable spectrometer is used to obtain a light spectrum of the medication. A subject identification or biometric device is used to identify the patient. A controller coupled to the portable spectrometer and the subject identification device identifies the medication by performing a chemometric analysis of the light spectrum. Based on the medication identified and the patient identified, the controller can determine if the medication is to be taken by the patient.

Patent Agency Ranking